Modele funkcji poznawczych względem wybranych parametrów stanu funkcjonalnego tarczycy u kobiet po menopauzie

Gujski, Mariusz; Pinkas, Jarosław; Witczak, Mariusz; Owoc, Alfred; Bojar, Iwona

doi:10.5603/ep.2017.0022

Cited by 4 publications

(1 citation statement)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There was a significant negative correlation between the level of anti-thyroid Ab and cognitive ability, as well as a negative correlation between fT4 level and cognitive function. 122 In an elderly female population (aged 65 years and older), 82% of the population had cognitive deficit in at least one domain. 123…”

Section: Thyroid Hormone S and Cog Niti On In Womenmentioning

confidence: 99%

The relation between thyroid dysregulation and impaired cognition/behaviour: An integrative review

Eslami‐Amirabadi

2021

J Neuroendocrinology

View full text Add to dashboard Cite

Prevalence of cognitive impairment and dementia substantially increases with ageing, especially in the oldest old population. 1 Thyroid disorders are also prevalent in the elderly population, with the prevalence of hypo-and hyperthyroidism reaching 30% and 10% respectively. 2,3 It has been long noted that disorders of thyroid function can lead to cognitive impairment. Therefore, thyroid dysfunctions are important and potentially modifiable risk factors of cognitive impairment in the older individuals. 4 Thyroid dysfunctions can be categorised based on the serum levels of thyroid hormones (thyroxine [T4] and triiodothyronine [T3]) and thyroid-stimulating hormone (TSH) level as: overt hypothyroidism: decreased T4/T3 levels and increased TSH; overt hyperthyroidism: increased T4/T3 and decreased TSH; subclinical hypothyroidism: normal T4/T3 levels with increased TSH; and subclinical hyperthyroidism: normal T4/T3 levels and decreased TSH level. 4 The association of hypo-or hyperthyroidism with cognition and behaviour has been investigated in many experimental animal studies, 5-7 and also in human observational and experimental studies, as well as clinical trials. 8-11 The objectives of this review are: • To provide a summary of the spectrum of cognitive and behavioural impairments related to thyroid disorders

show abstract

Section: Thyroid Hormone S and Cog Niti On In Womenmentioning

confidence: 99%

The relation between thyroid dysregulation and impaired cognition/behaviour: An integrative review

Eslami‐Amirabadi

2021

J Neuroendocrinology

View full text Add to dashboard Cite

show abstract

Efficacy of Withania somnifera supplementation on adult’s cognition and mood

Remenapp

Coyle

Orange

et al. 2022

Journal of Ayurveda and Integrative Medicine

View full text Add to dashboard Cite

The present study examined the effects of a proprietary Ashwagandha ( Withania somnifera ) root and leaf extract (NooGandha® Specnova LLC, USA) supplement for improving cognitive abilities, cortisol levels, and self-reported mood, stress, food cravings, and anxiety with adults who have perceived stress. Healthy adults ( n = 43 women and n = 17 men; mean age = 34.41 years) who reported experiencing perceived stress were randomized to the following groups: Ashwagandha (400 mg/d), Ashwagandha (225 mg/d), and placebo for 30 days. The following outcomes were assessed at Day 0, Day 15, and Day 30: saliva cortisol levels, cognitive performance (i.e., CNS vital signs), and the self-reported measures of Trait Anxiety Inventory, Depression Anxiety Stress Scale, Perceived Stress Scale, and Food Cravings Questionnaire-15. For the self-report assessments, significant main effects for time were evidenced for anxiety, depression, perceived stress, and food cravings, p 's < 0.01. The main effect for group and the interactions were non-significant. For the CNS vital signs, significant differences were observed in cognitive flexibility, visual memory, reaction time, psychomotor speed, and executive functioning, p 's < 0.05, with the Ashwagandha groups often out-performing the placebo group. Both Ashwagandha groups had reductions in cortisol levels over time, with significant reductions evidenced for the Ashwagandha 225 mg/d group from Day 0 to Day 15 to Day 30. The placebo group had a non-significant increase in cortisol levels from Day 0 to Day 15–30. No adverse events were reported. In conclusion, Ashwagandha supplementation may improve the physiological, cognitive, and psychological effects of stress.

show abstract

Thyroid functions in patients with hypochondriasis

Namli¹

2022

North Clin Istanbul

View full text Add to dashboard Cite

OBJECTIVE No studies of thyroid-related hormone levels have been conducted in patients with hypochondriasis to date. The aim of this study is to examine thyroid-related hormones in patients with hypochondriasis. METHODS Sixty patients with hypochondriasis and 138 healthy controls were included in this study. Patients with hypochondriasis who applied to the psychiatry outpatient clinic and met the study criteria and healthy controls were determined by chart analysis. RESULTS According to the results of the comparisons, TSH, fT3, and fT4 levels did not show a statistically significant difference between hypochondriasis patients and healthy controls. CONCLUSION Thyroid hormone levels are not associated with hypochondriasis.

show abstract

Modele funkcji poznawczych względem wybranych parametrów stanu funkcjonalnego tarczycy u kobiet po menopauzie

Cited by 4 publications

References 35 publications

The relation between thyroid dysregulation and impaired cognition/behaviour: An integrative review

The relation between thyroid dysregulation and impaired cognition/behaviour: An integrative review

Efficacy of Withania somnifera supplementation on adult’s cognition and mood

Thyroid functions in patients with hypochondriasis

Contact Info

Product

Resources

About